Searching journal content for articles similar to Vitale et al. 24 (1): R1.

Displaying results 1-10 of 1072
For checked items
  1. Thematic Review:
    • Hermine Mohr and
    • Natalia S Pellegata
    Animal models of MEN1 Endocr Relat Cancer 24 (10) T161-T177, doi:10.1530/ERC-17-0249 first published on 25 July 2017
    ...between human, rat, mouse, zebrafish and Drosophila (Marini et al. 2009, http://www.umd.be/MEN1/) (Fig. 1B). No genotype–phenotype correlation has been found in MEN1 as individuals with the same MEN1 mutation may have different clinical presentations. To date, several animal models of MEN1, or having...
  2. Review:
    • Samantha Peiling Yang and
    • Joanne Ngeow
    Familial non-medullary thyroid cancer: unraveling the genetic maze Endocr Relat Cancer 23 (12) R577-R595, doi:10.1530/ERC-16-0067
    ...DOI: 10.1530/ERC-16-0067 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 23:12 Review S Peiling Yang and J Ngeow Familial non-medullary thyroid cancer review 10.1530/ERC-16-0067 Samantha Peiling Yang1,2 and Joanne Ngeow3...
  3. Review:
    • Christine Spitzweg,
    • John C Morris,
    • and Keith C Bible
    New drugs for medullary thyroid cancer: new promises? Endocr Relat Cancer 23 (6) R287-R297, doi:10.1530/ERC-16-0104 first published on 16 May 2016
    ...DOI: 10.1530/ERC-16-0104 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. Abstract Medullary thyroid cancer (MTC) is a rare tumor arising from the calcitonin-producing parafollicular C cells of the thyroid gland, occurring...
  4. Regular papers:
    • Joanna Klubo-Gwiezdzinska,
    • Kirk Jensen,
    • John Costello,
    • Aneeta Patel,
    • Victoria Hoperia,
    • Andrew Bauer,
    • Kenneth D Burman,
    • Leonard Wartofsky,
    • and Vasyl Vasko
    Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells Endocr Relat Cancer 19 (3) 447-456, doi:10.1530/ERC-12-0046 first published on 2 March 2012
    ...Victoria Hoperia2, Andrew Bauer, Kenneth D Burman1, Leonard Wartofsky1 onadherent conditions. Immunostaining of in patients. Medullary thyroid cancer (MTC) derives from paraf- of 100, 93, 71, and 21% for stages I, II, III, and IV Endocrine-Related Cancer (2012) 19 447–456(Pelizzo et al. 2007...
  5. Regular papers:
    • B Cosci,
    • A Vivaldi,
    • C Romei,
    • F Gemignani,
    • S Landi,
    • R Ciampi,
    • A Tacito,
    • E Molinaro,
    • L Agate,
    • V Bottici,
    • V Cappagli,
    • D Viola,
    • P Piaggi,
    • P Vitti,
    • A Pinchera,
    • and R Elisei
    In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer Endocr Relat Cancer 18 (5) 603-612, doi:10.1530/ERC-11-0117 first published on 2 August 2011
    ...Wild-type AA/nucleotides Mutatio AA/nucleot 338 5 Thr/ACC Ile/ATC 648 11 Val/GTC Ile/ATC 848 14 Met/ATG Thr/AC 904 15 Ser/TCC Phe/TTC 883 15 Ala/GCT Thr/AC 918 new 16 Met/ATG Val/GT AA, amino acid; MTC, medullary thyroid cancer; n, number of c aThis subject had only C-cell hyperplasia; the family...
  6. Research:
    • Antonella Verrienti,
    • Giovanni Tallini,
    • Chiara Colato,
    • Amélie Boichard,
    • Saula Checquolo,
    • Valeria Pecce,
    • Marialuisa Sponziello,
    • Francesca Rosignolo,
    • Dario de Biase,
    • Kerry Rhoden,
    • Gian Piero Casadei,
    • Diego Russo,
    • Michela Visani,
    • Giorgia Acquaviva,
    • Marco Ferdeghini,
    • Sebastiano Filetti,
    • and Cosimo Durante
    RET mutation and increased angiogenesis in medullary thyroid carcinomas Endocr Relat Cancer 23 (8) 665-676, doi:10.1530/ERC-16-0132 first published on 8 July 2016
    ...DOI: 10.1530/ERC-16-0132 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. Abstract Advanced medullary thyroid cancers (MTCs) are now being treated with drugs that inhibit receptor tyrosine kinases, many of which involved...
  7. Review:
    • Jolanta Krajewska,
    • Ewa Chmielik,
    • and Barbara Jarząb
    Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017? Endocr Relat Cancer 24 (11) R387-R402, doi:10.1530/ERC-17-0270 first published on 18 August 2017
    ...stratification. We also provided some data concerning the use of dynamic risk stratification in medullary thyroid cancer, not yet reflected in ATA guidelines. In conclusion, dynamic risk stratification allows for better prediction of the risk of recurrence in thyroid carcinoma, what has been demonstrated...
  8. Review:
    • Giovanni Vitale,
    • Germano Gaudenzi,
    • Alessandra Dicitore,
    • Franco Cotelli,
    • Diego Ferone,
    • and Luca Persani
    Zebrafish as an innovative model for neuroendocrine tumors Endocr Relat Cancer 21 (1) R67-R83, doi:10.1530/ERC-13-0388 first published on 29 November 2013
    ....1530/ERC-13-0388 Printed in Great BritainThe potential role of surrounding tissue microenvironment in the pathogenesis of medullary thyroid cancer (MTC) may be investigated using zebrafish as model. In humans C-cells are dispersed throughout the thyroid parenchyma, whereas in zebrafish this cell type...
  9. Regular papers:
    • Andreas Machens,
    • Florian Hoffmann,
    • Carsten Sekulla,
    • and Henning Dralle
    Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer Endocr Relat Cancer 16 (4) 1291-1298, doi:10.1677/ERC-09-0136 first published on 2 September 2009
    ...ver (Correspondence should be addressed to A Machens; Email: [email protected]) Originating from parafollicular C-cells, medullary storing, and releasing calcitonin into the bloodstream. Because they broadly reflect overall C-cell mass reening, the prevalence of medullary thyroid cancer has...
  10. Regular Papers:
    • Paolo Miccoli,
    • Michele N Minuto,
    • Clara Ugolini,
    • Eleonora Molinaro,
    • Fulvio Basolo,
    • Piero Berti,
    • Aldo Pinchera,
    • and Rossella Elisei
    Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer Endocr Relat Cancer 14 (4) 1099-1105, doi:10.1677/ERC-07-0128
    ...by the early lymphatic spreading of the tumour, leading to a high incidence of node metastases in all compartments of the neck. It iswell known that the presence of nodemetastases is a negative prognostic factor, so that an early diagnosis,with medullary thyroid cancer (MTC). According to the American...
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. November 2017, 24 (11)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most